Peer Review History

Original SubmissionAugust 29, 2022
Decision Letter - Maria Elisabeth Johanna Zalm, Editor

PONE-D-22-22179The impact of injury of the chorda tympani nerve during primary stapes surgery or cochlear implantation on taste function, quality of life and food preferences: a study protocol for a prospective prognostic trialPLOS ONE

Dear Dr. Blijleven,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Your manuscript has been assessed by two peer-reviewers and their reports are appended below.  The reviewers' comment that your study would be strengthened by additional details and clarifications, for example for the study design, guidelines, and statistical analysis. In addition, the reviewers have made suggestions on the data collection and exclusion criteria proposed in this study protocol.  The reviewers have recommended a number of citations as a part of their review. We would recommend that you thoroughly evaluated these requested references and determine whether the articles are relevant to the current study. You may feel free to disregard references with tangible relevance to the study reported in the manuscript. Could you please revise the manuscript to carefully address the concerns raised?

Please submit your revised manuscript by Jan 25 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Maria Elisabeth Johanna Zalm, Ph.D

Editorial Office

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is an interesting double-blind prognostic study, designed to investigate the effect of CTN injury on postoperative taste function, defined as the postoperative taste strip score, in patients undergoing primary stapes surgery or primary cochlear implantation.

1. This has been stated to be a prognostic study- can the authors be more explicit in terms of design , i.e whether this is a description, association, prediction and causation, from the stats methods, its suggestive of either description or association.

2. And consider whether these guidelines need to be used; PROGRESS, TRIPOD and CHARMS

3. Pre-specified covariates have been stated to include 14 variables. In the statistical analysis section, it would make sense to include univariate analysis of these covariates.

4. In addition state, are the authors going to consider multicollinearity?

5. Any consideration of moderators or mediating factors?

6. In the statistical analysis section, it might also be useful to include that, if assumption of normality are violated for the continuous outcome i.e the primary outcome - non parametric methods will be used.

Reviewer #2: The reviewer thanks for the opportunity to analyze this work. It is a good written protocol. However, I have some suggestions:

- Converted all “we…” in passive form.

- Ear malformation should be considered in the exclusion criteria

- Better describe surgical procedure performed and the type of method (endoscopic or microscopic).

Read: (doi:10.1177/0194599821990669; DOI: 10.5152/iao.2017.3322; DOI: 10.7874/jao.2021.00388).

- Eventual other post-surgical complications should be collected.

- Why will you not perform some valuations at all follow-up times? for example, the olfactory function evaluation?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Dr. Maria Elisabeth Johanna Zalm,

Thank you for considering our manuscript. Enclosed you will find our answers to the questions.

Yours sincerely,

Esther E. Blijleven, Robert J. Stokroos, Inge Wegner and Hans G.X.M. Thomeer

Journal Requirements

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Answer: Thank you for your comments. We have changed the filenames and the manuscript conforms to the style requirements.

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide.

Answer: This manuscript is a study protocol. We cannot share any data because we do not have results yet. The intention is to submit the manuscript containing the results of this study to PLOS one. We will publish an anonymized data set of the results of our research at that time.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Answer: We have moved the ethics statement from the declaration section to the methods section. (see page 15-16, line 379-388)

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Answer: We have included a caption of the supporting information files at the end of our manuscript. (see page 20, line 496-499)

Reviewer 1

This is an interesting double-blind prognostic study, designed to investigate the effect of CTN injury on postoperative taste function, defined as the postoperative taste strip score, in patients undergoing primary stapes surgery or primary cochlear implantation.

Answer: Thank you for your comments.

1. This has been stated to be a prognostic study- can the authors be more explicit in terms of design , i.e whether this is a description, association, prediction and causation, from the stats methods, its suggestive of either description or association.

Answer: The study is a prognostic association study. Addition manuscript: Double-blind prospective prognostic association study (see page 1, line 4-5; page 3, line 54 and page 7, line 146)

2. And consider whether these guidelines need to be used; PROGRESS, TRIPOD and CHARMS

Answer: We will not make a prediction model with the results, so the PROGRESS, TRIPOD, CHARMS guidelines are not applicable to our study.

3. Pre-specified covariates have been stated to include 14 variables. In the statistical analysis section, it would make sense to include univariate analysis of these covariates.

Answer: We will also perform univariate analysis of these covariates. Addition manuscript: Univariable and multivariable analysis will be performed. (see page 15, line 360-361)

4. In addition state, are the authors going to consider multicollinearity?

Answer: We will consider (multi)collinearity by assessing the Variation Inflation Factor (VIF) for each independent variable in SPSS. Additon manuscript: Multicollinearity will be considered by assessing the Variation Inflation Factor (VIF) for each independent variable in SPSS. (see page 15, line 357-359)

5. Any consideration of moderators or mediating factors?

Answer: We will consider effect modification by introducing interaction terms into the multivariable model (predictor*potential effect modifier). Addition manuscript: effect modification will be considered by introducing interaction terms into the multivariable model (predictor*potential effect modifier). (see page 15, line 359-360)

6. In the statistical analysis section, it might also be useful to include that, if assumption of normality are violated for the continuous outcome i.e the primary outcome - non parametric methods will be used.

Answer: We will use non-parametric methods if assumption of normality is violated. Addition manuscript: Parametric methods will be used if data are normally distributed and non-parametric methods will be used if assumption of normality is violated. (see page 14, line 349-350)

Reviewer 2

The reviewer thanks for the opportunity to analyze this work. It is a good written protocol.

Answer: Thank you for your comments.

1. Converted all “we…” in passive form.

Answer: We have converted all text from active to passive. (see manuscript)

2. Ear malformation should be considered in the exclusion criteria.

Answer: Ear malformation is an exclusion criteria. Addition manuscript: Exclusion criteria: ear malformation. (see page 8, line 175)

3. Better describe surgical procedure performed and the type of method (endoscopic or microscopic).

Read: (doi:10.1177/0194599821990669; DOI: 10.5152/iao.2017.3322; DOI: 10.7874/jao.2021.00388).

Answer: The surgical method will be microscopic for all surgeries.

4. Eventual other post-surgical complications should be collected.

Answer: We will collect all adverse events, including all post-surgical complications.

5. Why will you not perform some valuations at all follow-up times? for example, the olfactory function evaluation?

Answer: We will not perform the Sniffin’ Sticks test at all follow-up times to limit the burden on patients. The Institutional Review Board of the UMCU closely monitors the burden of patients participating in research and therefore we must be critical of the tests to which we expose the patient. After consultation of the Institutional Review Board of the UMCU we have decided to only perform the Sniffin’ Sticks test twice, because we expect the sense of smell does not change (much) over time.

Attachments
Attachment
Submitted filename: Response to reviewers.pdf
Decision Letter - Annalisa Pace, Editor

The impact of injury of the chorda tympani nerve during primary stapes surgery or cochlear implantation on taste function, quality of life and food preferences: a study protocol for a double-blind prospective prognostic association study

PONE-D-22-22179R1

Dear Dr. Blijleven

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Annalisa Pace

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #3: Partly

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #3: Partly

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #3: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I have no further comments.

All comments have been addressed.

Reviewer #3: Dear authors,

this is NOT the first study to validate quantify the efect of CT nerve injury on taste function. Chek and include papers of Perez R, Božanić Urbančič N.

The electrogustometry is not a standard testing procedure; how are you going to perform it "on one side of the tounge"?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: Yes: Saba Battelino

**********

Formally Accepted
Acceptance Letter - Annalisa Pace, Editor

PONE-D-22-22179R1

The impact of injury of the chorda tympani nerve during primary stapes surgery or cochlear implantation on taste function, quality of life and food preferences: a study protocol for a double-blind prospective prognostic association study

Dear Dr. Blijleven:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Annalisa Pace

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .